about
Recurrent hypersplenism caused by giant accessory spleen due to portal hypertension after splenectomia.Endoscopic alcohol injection therapy of giant gastric leiomyomas: an alternative method to surgery.The Diagnostic Value of Endoscopic Balloon Catheter Usage for Detecting Early-Stage Primary Sclerosing Cholangitis in Endoscopic Retrograde Cholangiopancreatography: A Case Report.Endoscopic retrograde cholangiopancreatography in the diagnosis and management of choledochal cystsApoptosis in selected liver diseases.No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.New Paradigm: Adaptive Approach.Vitamin D ameliorates stress ligand expression elicited by free fatty acids in the hepatic stellate cell line LX-2.Massive lower gastrointestinal hemorrhage secondary to rectal hemorrhoids in elderly patients receiving anticoagulant therapy: case series.Association between chronic hepatitis B virus infection and HLA-DP gene polymorphisms in the Turkish population.Effect of PON1 gene polymorphisms in Turkish patients with hepatocellular carcinoma.Relationship between IL28B gene rs8099917 polymorphism and SVR in Turkish patients with hepatitis C virus genotype 1.Molecular characterization of a full genome Turkish hepatitis C virus 1b isolate (HCV-TR1): a predominant viral form in Turkey.Potential benefits of combined N-acetylcysteine and ciprofloxacin therapy in partial biliary obstruction.Management of an esophageal metallic stent obstructed by tumor progression: endoscopic alcohol injection therapy instead of restenting.Giant subcutaneous HCC case occurring after percutaneous ethanol injection.Expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?CHK2 1100delC, IVS2+1G>A and I157T mutations are not present in hepatocellular cancer cases from a Turkish population.Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients.Diagnosis, management and treatment of hepatitis delta virus infection: Turkey 2017 Clinical Practice Guidelines.Diagnosis, management and treatment of hepatitis B virus infection: Turkey 2017 Clinical Practice Guidelines.CHEK2 1100delC, IVS2+1G>A and I157T mutations are not present in colorectal cancer cases from Turkish population.The significance of Exonuclease 1 K589E polymorphism on hepatocellular carcinoma susceptibility in the Turkish population: a case-control study.Lack of an association of programmed cell death-1 PD1.3 polymorphism with risk of hepatocellular carcinoma susceptibility in Turkish population: a case-control study.p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study.The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population.Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study.Macroscopic Portal Vein Thrombosis in HCC Patients.C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor Markers in Low-Alpha-Fetoprotein Hepatocellular CarcinomaHepatocellular Carcinoma: From Molecular Basis to Novel Treatment ApproachesExpression of mesenchymal, hematopoietic, and biliary cell markers in adult rat hepatocytes after partial hepatectomyFunctional polymorphisms of cyclooxygenase-2 gene and risk for hepatocellular carcinomaNew therapeutic option with N-acetylcysteine for primary sclerosing cholangitis: two case reportsAtherosclerosis and acetylsalicylic acid are independent risk factors for hemorrhage in patients with gastric or duodenal ulcerNegative correlation between viral load and HBsAg levels in chronic HBV-infected patientsG-308A TNF-alpha polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control studyEconomic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries
P50
Q33387415-010DC7AF-746A-4034-9E87-FD2DACFD7433Q34169223-7B52DB11-67D5-4914-9DB9-25D2E479B1D3Q34336235-9120622D-484E-4C3F-8A69-B344EE860D14Q36712789-9DD5FFD4-B367-4787-B3A1-4B5BE50355C2Q37612987-18493543-507C-49AA-A663-22C5C0BA11DBQ38332959-5117D608-5D44-45D1-BE2B-A1E23003B134Q39406277-ED637CE2-5D23-4234-BFE6-802FBD73A320Q39467879-86AA611C-D95C-4345-8CB0-84D0A66ADB57Q39910318-56F67D33-A669-4129-BB56-89F93E1B7986Q40359673-F03529C6-27FD-472E-A687-8F0C9778F547Q41551383-C1DC3D61-4F1F-4594-A7B0-52E42FEF18A1Q42149762-C6A648D6-CC47-4E3E-9E02-9BA74E214946Q42687308-49E20489-8DFD-44B1-8293-71FA68B841DBQ43100915-330F26ED-B9B8-4D1D-9DA3-A4E524A2A77CQ43145240-91C49739-79DC-4082-86EB-A75575543522Q43190343-3DD44469-B330-4D01-8B84-F6999CEEB1FAQ45397037-3ED920BA-5C48-4508-A305-2D7AE075E580Q46077452-D1AF40F7-3373-4EE6-92B3-EB2CCBA22C5CQ47328128-1107BF2C-3FE5-4AEF-B5C3-E00080205AB4Q47557883-9FCFFD84-4002-48C7-BA0B-27F2550CE657Q47557888-1D6EFE7F-F64F-4833-BF6A-17DCE5EDB801Q53173027-19A67DE7-BBE9-4C17-A9C3-057B0E195D5CQ53195871-318D7113-4CE9-4574-BAA3-A9CD7BCD53BFQ53263677-BFFFDAF2-5408-4048-BCB7-3FEEC29E1C8DQ53286606-CEEFEBA5-E3E1-441C-9A16-9A896B3890E0Q54389179-D1FCF1D6-BF77-4A9B-B634-CE4164218A51Q54434859-28F0DC25-A9D6-42D7-89FA-70A7D76003EEQ55712348-31753048-F501-4942-9380-327E62465F4EQ58600777-F5FC85F2-C63F-4952-9C31-6A14DC98935EQ64070536-4FA74106-2D57-471B-973B-F6B5C392A6B7Q82221077-4C421CAF-7E11-4CC5-81F1-36C7636D9375Q82270879-D1960596-24FB-4D05-8E3A-37A8DC97226CQ82283195-142D9E36-25B6-483C-9809-03E98CAB5336Q83160797-16C0E99C-9438-4DA4-80E4-D590F9C114FBQ84389499-583EF064-7F89-45F3-B115-0CA1931B6518Q84409532-CB94FACC-A7B7-49B5-B314-777A3E0C1BEEQ95492298-708F74BA-E163-437B-9794-6BED4F1FE27E
P50
description
researcher
@en
wetenschapper
@nl
name
H Akkiz
@en
H Akkiz
@nl
type
label
H Akkiz
@en
H Akkiz
@nl
prefLabel
H Akkiz
@en
H Akkiz
@nl
P106
P31
P496
0000-0001-9745-8875